Boston Sci closes on $4.3 billion deal for British health company BTG
Boston Sci is adding jobs in the Twin Cities to manage cancer treatments and vascular devices acquired in the deal.
Boston Sci is adding jobs in the Twin Cities to manage cancer treatments and vascular devices acquired in the deal.